CN106977463A - A kind of synthetic method of biphenyl substituted piperazine derivatives - Google Patents

A kind of synthetic method of biphenyl substituted piperazine derivatives Download PDF

Info

Publication number
CN106977463A
CN106977463A CN201710401796.5A CN201710401796A CN106977463A CN 106977463 A CN106977463 A CN 106977463A CN 201710401796 A CN201710401796 A CN 201710401796A CN 106977463 A CN106977463 A CN 106977463A
Authority
CN
China
Prior art keywords
reaction
prepare compound
xylene
temperature
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201710401796.5A
Other languages
Chinese (zh)
Inventor
邓泽平
陈芳军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Huateng Pharmaceutical Co Ltd
Original Assignee
Hunan Huateng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Huateng Pharmaceutical Co Ltd filed Critical Hunan Huateng Pharmaceutical Co Ltd
Priority to CN201710401796.5A priority Critical patent/CN106977463A/en
Publication of CN106977463A publication Critical patent/CN106977463A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

The invention discloses a kind of synthetic method of biphenyl substituted piperazine derivatives 4 (base of N Boc piperazines 3) biphenyl; using 4 acetyl biphenyls as initiation material; target product is obtained through peroxidating, cyclization, upper Boc, the compound is important medicine intermediate.

Description

A kind of synthetic method of biphenyl substituted piperazine derivatives
Technical field
The present invention relates to a kind of novel processing step of medicine intermediate, more particularly to a kind of biphenyl substituted piperazine derivatives A kind of synthesis technique of 4- (N-Boc- piperazine -3- bases) biphenyl.
Technical background
Biphenyl substituted piperazine derivatives 4- (N-Boc- piperazine -3- bases) biphenyl, structural formula is:
Antimicrobial agents are a current clinical practice relatively wide, class medicines of large usage quantity, in control and treatment disease side Face is played an important role.The antimicrobial agents kind of current Clinical practice is numerous, but a large amount of with antimicrobial agents And widely use, irrational use particularly clinically, or even abuse, finally result in multidrug resistant.Therefore, how to overcome Multidrug resistant turns into the important topic of antimicrobial agents research both at home and abroad at present.The method for solving drug resistance is numerous, wherein newly The research and development of type structure antimicrobial agents are to solve one of important channel of drug resistance, it has also become current pharmaceutical chemistry is very active Field.
Piperazine ring is the class basic group commonly used in pharmaceutical chemistry research, its small toxicity, easily formed multiple hydrogen bonds or from Sub-key, often can the effectively lipid of regulating drug and acid-base balance constant.Molecule is introduced into, can effectively be increased The alkaline and water solubility of molecule, so as to strengthen the activity of molecule.Therefore, to a certain extent, piperazine group is a synergy base Group, often introduces in the design and exploitation of many medicines.Research shows that the compound replaced containing piperazine and N- is often shown extensively Bioactivity, such as antimicrobial, anti-hypertension, anticancer, anti-inflammatory and analgesic, especially as antimicrobial agents, it is studied Enliven and quickly grow, show the development potentiality of broadness.
Class bridged piperazine derivatives intermediate of the present invention plays an important roll for new drug development.
The content of the invention
The invention discloses a kind of synthetic method of biphenyl substituted piperazine derivatives 4- (N-Boc- piperazine -3- bases) biphenyl, Using 4- acetyl biphenyls as initiation material, target product is obtained through peroxidating, cyclization, upper Boc, synthesis step is as follows:
(1) using 4- acetyl biphenyls as initiation material, oxidized reaction obtains 2;
(2) occur ring-closure reaction with ethylenediamine 3, obtain 3;
(3) 3 and Boc2O reactions obtain 4;
In a preferred embodiment, the oxidising agent used in described oxidation reaction prepare compound 2 is selected from dioxy Change selenium;Reducing agent used in described ring-closure reaction prepare compound 3 is selected from sodium borohydride;Described amido protecting reaction is used Alkali be selected from sodium acid carbonate.
In a preferred embodiment, the solvent used in described oxidation reaction prepare compound 2 is selected from tetrahydrofuran; Solvent used in described ring-closure reaction prepare compound 3 is selected from ethanol;Described amido protecting reaction solvent used is selected from Dichloromethane.
In a preferred embodiment, the reaction temperature used in described oxidation reaction prepare compound 2 is solvent Reflux temperature;Temperature used in described ring-closure reaction prepare compound 3 is the reflux temperature of solvent;Described amido protecting is anti- Temperature that should be used is room temperature.
The present invention relates to the synthesis technique of biphenyl substituted piperazine derivatives 4- (N-Boc- piperazine -3- bases) biphenyl, do not have at present There is other Patents documents report.
The present invention is further described by the following embodiment, and these descriptions are not present invention to be made into one The restriction of step.It should be understood by those skilled in the art that the equivalent substitution made to the technical characteristic of the present invention, or change accordingly Enter, still fall within protection scope of the present invention.
Specific embodiment mode
Embodiment 1
(1) synthesis of 4- (two glyoxals) biphenyl
20g 4- acetyl biphenyls are added in 150ml tetrahydrofurans, 45g selenium dioxide, heating stirring backflow is added 12 hours, room temperature is cooled to, is filtered, is added water and ethyl acetate is extracted, point liquid, drying, concentration obtain crude product two Glyoxal is recrystallized to give 11g 4- (two glyoxals) biphenyl to bromobenzene.
(2) synthesis of 4- piperazines biphenyl
10g 4- (two glyoxals) biphenyl is added in 130ml ethanol, 8.5g ethylenediamines is added, is heated to reflux 6 Hour, room temperature is cooled to, 3.8g sodium borohydrides are added portionwise, is stirred at room temperature 4 hours, 1N hydrochloric acid is added, adds ethyl acetate, Extraction point liquid, collects organic phase, point liquid, drying, concentration, and silica gel post separation obtains 9.5g 4- piperazine biphenyl on residue.
(3) synthesis of 4- (N-Boc- piperazine -3- bases) biphenyl
9g 4- piperazine biphenyl is added in 100ml dichloromethane, 9.8g di-tert-butyl dicarbonates, the second of 3ml tri- is added Amine, is stirred at room temperature 24 hours, adds water, and extraction point liquid collects organic phase, point liquid, drying, concentration, silicagel column point on residue From 12.4g 4- (N-Boc- piperazine -3- bases) biphenyl.

Claims (6)

1. a kind of synthetic method of biphenyl substituted piperazine derivatives 4- (N-Boc- piperazine -3- bases) biphenyl, it is characterized in that with 4- second Acyl group biphenyl is initiation material, obtains target product 4 through peroxidating, cyclization, upper Boc, synthetic route is as follows:
2. method according to claim 1, it is characterized in that described 3 steps reaction is,
(1) using 4- acetyl biphenyls as initiation material, oxidized reaction obtains 2;
(2) occur ring-closure reaction with ethylenediamine 3, obtain 3;
(3) 3 and Boc2O reactions obtain 4;
3. method according to claim 1, it is characterised in that the oxidising agent used in described oxidation reaction prepare compound 2 One or more of mixtures in manganese dioxide, selenium dioxide, pyridine chlorochromate, pyridinium dichromate, chromium trioxide; Reducing agent used in described ring-closure reaction prepare compound 3 be selected from lithium borohydride, sodium borohydride, potassium borohydride, Lithium Aluminium Hydride, One or more of mixtures in sodium cyanoborohydride, sodium triacetoxy borohydride;Described amido protecting reaction is used Alkali be selected from sodium hydroxide, potassium hydroxide, lithium hydroxide, sodium carbonate, potassium carbonate, triethylamine, sodium acid carbonate, pyridine, three isopropyls One or more of mixtures in base amine, saleratus.
4. method according to claim 1, it is characterised in that the solvent used in described oxidation reaction prepare compound 2 is selected from Methanol, ethanol, normal propyl alcohol, isopropanol, tetrahydrofuran, toluene, ortho-xylene, paraxylene, meta-xylene, N, N- dimethyl methyls One or more of mixtures in acid amides, DMAC N,N' dimethyl acetamide;It is molten used in described ring-closure reaction prepare compound 3 Agent is selected from methanol, ethanol, isopropanol, dichloromethane, chloroform, ethyl acetate, tetrahydrofuran, toluene, tetrahydrofuran, first One or more in benzene, ortho-xylene, paraxylene, meta-xylene, N,N-dimethylformamide, DMAC N,N' dimethyl acetamide Mixture;Described amido protecting reaction solvent used is selected from methanol, ethanol, normal propyl alcohol, isopropanol, tetrahydrofuran, two Chloromethanes, chloroform, ethyl acetate, toluene, ortho-xylene, paraxylene, meta-xylene, N,N-dimethylformamide, N, One or more of mixtures in N- dimethyl acetamides.
5. method according to claim 1, it is characterised in that the reaction temperature used in described oxidation reaction prepare compound 2 It is the reflux temperature of 0 DEG C~solvent;Temperature used in described ring-closure reaction prepare compound 3 is the backflow temperature of 0 DEG C-solvent Degree;Described amido protecting reaction temperature used is the reflux temperature of 0 DEG C-solvent.
6. method according to claim 1, it is characterised in that the reaction temperature used in described oxidation reaction prepare compound 2 It is room temperature;Temperature used in described ring-closure reaction prepare compound 3 is the reflux temperature of solvent;Described amido protecting reaction Temperature used is room temperature.
CN201710401796.5A 2017-05-31 2017-05-31 A kind of synthetic method of biphenyl substituted piperazine derivatives Withdrawn CN106977463A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710401796.5A CN106977463A (en) 2017-05-31 2017-05-31 A kind of synthetic method of biphenyl substituted piperazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710401796.5A CN106977463A (en) 2017-05-31 2017-05-31 A kind of synthetic method of biphenyl substituted piperazine derivatives

Publications (1)

Publication Number Publication Date
CN106977463A true CN106977463A (en) 2017-07-25

Family

ID=59342736

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710401796.5A Withdrawn CN106977463A (en) 2017-05-31 2017-05-31 A kind of synthetic method of biphenyl substituted piperazine derivatives

Country Status (1)

Country Link
CN (1) CN106977463A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106854189A (en) * 2015-12-08 2017-06-16 湖南华腾制药有限公司 A kind of synthetic method of diethylenediamine compound

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101115717A (en) * 2005-02-10 2008-01-30 安万特药物公司 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
WO2015055698A1 (en) * 2013-10-16 2015-04-23 Boehringer Ingelheim International Gmbh Piperazine derivatives and the use thereof as medicament
CN106854189A (en) * 2015-12-08 2017-06-16 湖南华腾制药有限公司 A kind of synthetic method of diethylenediamine compound
CN107778257A (en) * 2016-08-29 2018-03-09 湖南华腾制药有限公司 A kind of synthetic method of bridged piperazine derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101115717A (en) * 2005-02-10 2008-01-30 安万特药物公司 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
WO2015055698A1 (en) * 2013-10-16 2015-04-23 Boehringer Ingelheim International Gmbh Piperazine derivatives and the use thereof as medicament
CN106854189A (en) * 2015-12-08 2017-06-16 湖南华腾制药有限公司 A kind of synthetic method of diethylenediamine compound
CN107778257A (en) * 2016-08-29 2018-03-09 湖南华腾制药有限公司 A kind of synthetic method of bridged piperazine derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YONG LI ET AL: ""Asymmetric Hydrogenation of 2-Aryl-5,6-dihydropyrazine Derivatives with Chiral Cationic Ruthenium Diamine Catalysts"", 《CHINESE JOURNAL OF CHEMISTRY》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106854189A (en) * 2015-12-08 2017-06-16 湖南华腾制药有限公司 A kind of synthetic method of diethylenediamine compound

Similar Documents

Publication Publication Date Title
CN105175328B (en) It is a kind of using aromatic amine, aromatic aldehyde, ketone synthesis of quinoline derivatives method
JPS5890567A (en) Heterocyclic compound, manufacture and cardiac stimulant and/or antihypertensive pharmaceutical composition containing same
CN109020881A (en) A kind of Ah pa replaces the preparation method of Buddhist nun
Khraiwesh et al. Antitrypanosomal activities and cytotoxicity of some novel imidosubstituted 1, 4-naphthoquinone derivatives
Huang et al. Synthesis and cytotoxic evaluation of a series of resveratrol derivatives modified in C2 position
CN111690947A (en) Electrochemical synthesis method of trifluoromethylated aryl amide derivative
CN107778257A (en) A kind of synthetic method of bridged piperazine derivatives
CN106977463A (en) A kind of synthetic method of biphenyl substituted piperazine derivatives
CN104945294B (en) Compound containing trifluoromethylthio and preparation method thereof
CN106957273A (en) A kind of preparation method of quinazolinone and its derivative
CN104974149B (en) A kind of preparation method of razaxaban
CN106854189A (en) A kind of synthetic method of diethylenediamine compound
CN105837528B (en) A kind of preparation method of 2- (methyl sulphonyl) -10H- phenthazine
Kumar et al. An efficient synthesis of 2-(1-methyl-1, 2, 5, 6-tetrahydropyridin-3-yl) morpholine: a potent M1 selective muscarinic agonist
CN106543194A (en) Narciclasine derivative and its preparation and the application in antineoplastic is prepared
CN109293649B (en) Sonchibu intermediate and preparation method of Sonchibu
CN101665441A (en) Method for preparing l-betaxolol hydrochloride
CN102432553A (en) Preparation method and intermediate of quinazoline derivative
CN108191751A (en) Bis- aryl methylene -4- piperidines ketone compounds of 3,5- of 4- fluorophenylsulphonyls substitution and preparation method thereof
BRPI0613693A2 (en) 8-alkoxy-4-methyl-3,4-dihydro-quinazolin-2-yl amines and their uses as 5-ht5a receptor binders
US3965181A (en) Tricyclic pharmacological agents, intermediates and methods of making
CN107286155A (en) The method for preparing 6,7- dihydro -5H- pyrrolopyridine hydrochlorides
CN110015960A (en) The preparation method and application of 1,3- bis- (4,4- methyl formate phenyl) acetone
CN105294562B (en) A kind of preparation method of the chloro- 5- oxo -2,3,4,5- tetrahydro -1H-1- benzazepine of 7-
CN103073520A (en) Method for synthesizing 2-phenyl benzothiazole and derivative thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20170725

WW01 Invention patent application withdrawn after publication